Abstract
Craniofacial pain, including trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain, is difficult to treat and can have severe implications for suffering in patients afflicted with these conditions. In recent years, clinicians have moved beyond treating solely with pharmacological therapies, which are generally not very effective, and focused on new interventional pain procedures. These procedures have evolved as technology has advanced, and thus far, early results have demonstrated efficacy in small patient cohorts with a variety of craniofacial pain states. Some of the most promising interventional pain procedures include peripheral nerve field stimulation, high-frequency spinal cord stimulation, sphenopalatine ganglion stimulation, and deep brain stimulation. This review focuses on a better understanding of craniofacial pain and emerging interventional pain therapies. With the advent of newer miniature wireless devices and less invasive implantation techniques, this should allow for more widespread use of neurostimulation as a therapeutic modality for treating craniofacial pain. Larger studies should assist in best practice strategies vis-à-vis traditional pharmacological therapies and emerging interventional pain techniques.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sharma M, Shaw A, Deogaonkar M. Surgical options for complex craniofacial pain. Neurosurg Clin N Am. 2014;25(4):763–75.
Stookey B, Ransohoff J. Trigeminal neuralgia. Its history and treatment. Springfield, IL: Charles C. Thomas; 1959.
Eboli P, Stone JL, Audin S, Slavin KV. Historical characterization of trigeminal neuralgia. Neurosurgery. 2009;64:1183–7.
Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review). Neurology. 2008;71:1183–90.
Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18(6):343–9.
Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524–34.
Hodaie M, Coello AF. Advances in the management of trigeminal neuralgia. J Neurosurg Sci. 2013;57:13–21.
Feletti A, Santi GZ, Sammartino F, et al. Peripheral trigeminal nerve field stimulation: report of 6 cases. Neurosurg Focus. 2013;35(3):E10.
Mueller D, Obermann M, Yoon MS, et al. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia. 2011;31(15):1542–8.
Headache Classification Committee. The international classification of headache disorders, 3rd edition (beta version). 5. Cephalalgia. 2013;33:629–808.
Obermann M, Holle D, Katsarava Z. Trigeminal neuralgia and persistent idiopathic facial pain. Expert Rev Neurother. 2011;11(11):1619–29.
Goadsby P, Hoskin K. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat. 1997;190:367–75.
Goadsby PJ, Bartsch T, Dodick D. Occipital nerve stimulation for headache: mechanisms and efficacy. Headache. 2008;48:313–8.
Hassanzadeh R, Jones JC, Ross EL. Neuromodulation for intractable headaches. Curr Pain Headache Rep. 2014;18(392):1–8.
Jannetta PJ, McLaughlin MR, Casey KF. Technique of microvascular decompression. Neurosurg Focus. 2005;18:1–5.
Koopman J, De Vries LM, Dieleman JP, Huygen FJ, Stricker BHC, Sturkenboom MCJM. A nationwide study of three invasive treatments for trigeminal neuralgia. Pain. 2011;152:507–13.
Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain. 2002;18:14–21.
Cole CD, Liu JK, Apfelbaum RI. Historical perspectives on the diagnosis and treatment of trigeminal neuralgia. Neurosurg Focus. 2005;18:1–10.
Ma Z, Li M. Nerve combing for trigeminal neuralgia without vascular compression. Clin J Pain. 2009;25:44–7.
Sekula Jr RF et al. Microvascular decompression for elderly patients with trigeminal neuralgia; a prospective study and systematic review with meta-analysis. J Neurosurg. 2011;114(1):172–9.
Zakrzewska J, Coakham HB. Microvascular decompression for trigeminal neuralgia. Curr Opin Neurol. 2012;25:296–301.
Zakrzewska J, Lopez BC. New techniques for surgical management of trigeminal neuralgia. Letter to the editor. Pain. 2004;109:520–9.
Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155(3758):108–9.
Ellis JA, Munne Mejia JC, Winfree CJ. Trigeminal branch stimulation for the treatment of intractable craniofacial pain. J Neurosurg. 2015;123:283–8.
Klein J, Sandi-Gahun S, Schackert G, Juratli TA. Peripheral nerve field stimulation for trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain. Cephalalgia. 2015;1–9. This case report shows the success of peripheral nerve field stimulation as a treatment for intractable facial pain, trigeminal neuralgia, and trigeminal neuropathic pain when first-line therapies have failed.
Deer TR, Mekhail N, et al. The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation: Technol Neural Interface. 2014;17.6:551–70. Based on the most current literature, research, and clinical experience, this review paper written by the Neuromodulation Appropriateness Consensus Committee concluded that extracranial nerve stimulation should be considered in the algorithmic treatment of migraine and other disorders of the head.
Yearwood L, Thomas PL. Peripheral neurostimulation with a microsize wireless stimulator. Prog Neurol Surg. 2015;29:168–91.
Bioness® StimRouterTM Neuromodulation System for Chronic Pain Therapy. http://clinicaltrials.gov/ct2/show/NCT01592344?term=stimrouter&rank=2.
Hudson J. Stimwave receives FDA clearance and launches commercialization for world’s smallest fully-programmable, eight-electrode wireless pain relief SCS system. Stimwave receives FDA clearance and launches commercialization for world’s smallest fully-programmable, eight-electrode wireless pain Relief SCS system. BUSINESS WIRE, 9 Dec. 2015. Web. This is the first FDA-approved commercially available wireless spinal cord stimulator implant. While not yet approved for facial pain, due to its small size and ease of implantation, this device would be ideal for the treatment of facial neuralgias.
Salar G, Ori C, Iob I, Fiore D. Percutaneous thermocoagulation for sphenopalatine ganglion neuralgia. Acta Neurochir. 1987;84:24–8.
Elahi F. Sphenopalatine ganglion electrical nerve stimulation implant for intractable facial pain. Pain Physician. 2015;18.3:403–9. This is the first reported case of sphenopalatine ganglion stimulation successfully used to treat intractable facial pain. This may offer another treatment option for those patients who have failed more conservative therapies.
Kapural L, Yu C, et al. Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain. Anesthesiology. 2015;123(4):851–60.
North RB, Kidd D, Shipley J, et al. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial. Neurosurgery. 2007;61(2):361–8.
Barolat G, Knobler RL, Lublin FD. Trigeminal neuralgia in a patient with multiple sclerosis treated with high cervical spinal cord stimulation. Case report. Appl Neurophysiol. 1988;51(6):333–7.
Simpson BA, Bassett G, Davies K, et al. Cervical spinal cord stimulation for pain: a report on 41 patients. Neuromodulation. 2003;6(1):20–6.
Tomycz ND, Deibert CP, Moossy JJ. Cervicomedullary junction spinal cord stimulation for head and facial pain. Headache. 2011;51(3):418–25.
Boccard SGJ, Pereira EAC. Deep brain stimulation for chronic pain. J Clin Neurosci. 2015;22(10):1537–43.
Kumar K, Toth C, Nath RK. Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery. 1997;40:736–46.
Nandi D, Smith H, Owen S, et al. Periventricular grey stimulation versus motor cortex stimulation for post stroke neuropathic pain. J Clin Neurosci. 2002;9:557–61.
Hosobuchi Y, Adams JE, Linchitz R. Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science. 1977;197:183–6.
Romanelli P, Esposito V. The functional anatomy of neuropathic pain. Neurosurg Clin N Am. 2004;15:257–68.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Rajivan Maniam, Alan David Kaye, and Nalini Vadivelu declare that they have no conflict of interest.
Richard D. Urman declares grants from Mallinckrodt, Inc. and Cara/Premier Pharma, Inc., and personal fees from Merck, Inc.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Other Pain
Rights and permissions
About this article
Cite this article
Maniam, R., Kaye, A.D., Vadivelu, N. et al. Facial Pain Update: Advances in Neurostimulation for the Treatment of Facial Pain. Curr Pain Headache Rep 20, 24 (2016). https://doi.org/10.1007/s11916-016-0553-0
Published:
DOI: https://doi.org/10.1007/s11916-016-0553-0